← Eichor
Study identifier: NCT07087873 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Assessment of Transcranial Alternating Current Stimulation's Clinical Efficacy in Treating Cognitive Impairment of Idiopathic Inflammatory Demyelinating Diseases

Condition: Idiopathic Inflammatory Demyelinating Disorders of the Central Nervous System · MS (Multiple Sclerosis) · NMOSD  ·  Sponsor: Xuanwu Hospital, Beijing

PhaseNA
Planned participants128
Who can joinAll sexes, 18 Years to 60 Years
Healthy volunteersNo

About this study

This study aims to explore the imaging and electrophysiological characteristics of idiopathic inflammatory demyelinating diseases (IIDDs), and their correlation with clinical manifestations. It also evaluates the effectiveness of transcranial electrical stimulation in alleviating clinical symptoms of IIDDs patients, and analyzes the key factors affecting the treatment efficacy. By uncovering the overall and individual characteristics of IIDDs, this study seeks to enhance therapeutic outcomes through personalized neuromodulation programs. The findings will provide a basis for applying non-invasive brain stimulation (NIBS) in IIDDs treatment and offer new ideas for future personalized medicine approaches.

This description comes directly from the study's public registry record.

Talk to the study team

huang huijin, Ph.D.  ·  +8618510510804  ·  huanghuijinmail@sina.com

Always discuss trial participation with your own doctor first.

Locations (1)

Xuanwu Hospital, Capital Medical UniversityBeijing, Beijing Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07087873